Gene · 28874
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comparison of four technologies for detecting p53 aggregates in ovarian cancer. | Front Oncol | 2022 | 36158680 | PubTator, text mining | PubMed |
| Human Error Probability Determination in Blasting Process of Ore Mine Using a Hybrid of HEART and Best-Worst Methods. | Saf Health Work | 2022 | 36156865 | PubTator, text mining | PubMed |
| Interactions between attributions and beliefs at trial-by-trial level: Evidence from a novel computer game task. | PLoS Comput Biol | 2022 | 36155635 | PubTator, text mining | PubMed |
| PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer. | Int J Biol Sci | 2022 | 36147463 | PubTator, text mining | PubMed |
| Histidine-Rich Glycoprotein Suppresses the S100A8/A9-Mediated Organotropic Metastasis of Melanoma Cells. | Int J Mol Sci | 2022 | 36142212 | PubTator, text mining | PubMed |
| Killer-Cell Immunoglobulin-like Receptor Diversity in an Admixed South American Population. | Cells | 2022 | 36139351 | PubTator, text mining | PubMed |
| A Closed-Loop Method for Multiperiod Intelligent Information Processing with Cost Constraints under the Fuzzy Environment. | Comput Intell Neurosci | 2022 | 36120700 | PubTator, text mining | PubMed |
| Marginal semiparametric transformation models for clustered multivariate competing risks data. | Stat Med | 2022 | 36117139 | PubTator, text mining | PubMed |
| A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode. | J Nanobiotechnology | 2022 | 36109732 | PubTator, text mining | PubMed |
| A Selective Adenosine A3 Receptor Antagonist, HL3501, Has Therapeutic Potential in Preclinical Liver and Renal Fibrosis Models. | In Vivo | 2022 | 36099145 | PubTator, text mining | PubMed |
| Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells. | EBioMedicine | 2022 | 36088683 | PubTator, text mining | PubMed |
| Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen. | Nat Commun | 2022 | 36088370 | PubTator, text mining | PubMed |
| HLA sharing and maternal HLA expression in couples with recurrent pregnancy loss in Taiwan. | Taiwan J Obstet Gynecol | 2022 | 36088055 | PubTator, text mining | PubMed |
| Polydopamine-Mediated Protein Adsorption Alters the Epigenetic Status and Differentiation of Primary Human Adipose-Derived Stem Cells (hASCs). | Front Bioeng Biotechnol | 2022 | 36032703 | PubTator, text mining | PubMed |
| Glutathione-Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation. | Molecules | 2022 | 36014491 | PubTator, text mining | PubMed |
| Upregulated integrin α11 in the stroma of cutaneous squamous cell carcinoma promotes skin carcinogenesis. | Front Oncol | 2022 | 36003785 | PubTator, text mining | PubMed |
| Nano-optomechanical Resonators for Sensitive Pressure Sensing. | ACS Appl Mater Interfaces | 2022 | 35994410 | PubTator, text mining | PubMed |
| Sports Injury Identification Method Based on Machine Learning Model. | Comput Intell Neurosci | 2022 | 35978906 | PubTator, text mining | PubMed |
| Lack of association of the KIR and HLA class I ligands with ZIKV infection in south and southeast of Brazil. | Mem Inst Oswaldo Cruz | 2022 | 35976280 | PubTator, text mining | PubMed |
| Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials. | J R Stat Soc Ser C Appl Stat | 2022 | 35968541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28874/papers?page=14